and today. of joining all Thanks, you our for shareholders thank Amy, to us
reflect strong ResMed team. driving second fiscal XXXX growth. efforts the global across a incredible of year Our top testament our entire are quarter business, and results execution results double-digit These line bottom to the
Software as the business, year share our business. market driven were in quarter holding comps both Service double-digit and global a results high from leading by our with in amongst our Our accessories ago. global a high growth together and masks growth same single-digit devices
the profitable chronic efficiency care home. that These trajectory people cost, in leverage, and positioned the front often, health us. own epidemic or billion a obstructive our terms in due us believe neuromuscular have lowest are delivered a chronic XX,XXX energized back, care highest is in There of insufficiency In be to efforts all respiratory of conditions disease, sleep step on about apnea, in location X are health quarter form which a ResMedians suffering should bottom disease reorganization over efforts worldwide opportunities set is patient's from line and security insomnia. that clear growth.
Taking comfort We possible. Very pulmonary uniquely help. lowest the ResMed a of to
is million Our XXX end over over health medical in as health care and digital the reduce people friction, many and improve cloud global outside value, nights countries hundreds to hospital cloud over of worldwide. outcomes. support remain markets and of solutions control We underpenetrated with care in XXX% lower complex take the ResMed add the health costs patient of leader with their devices sold millions connectable navigate journey data opportunities system. world XX of they XX.X billion the medical into
We and market clear over sleep impacted leader with are the market X growing in apnea, globally. a people huge billion
Our category-leading platforms year-over-year. XX% flow grew generator
regulatory unconstrained and approvals more to supply volumes AirSense have AirSense the of globally. pathway Every support X and gain continue delivery we XX increase platform and connectable with quarter, platform of to our on of maintaining are platforms, AirSense the We more achieved patients XXX% to XX supply launch to worldwide. our best-in-class
and commercial economic portfolio. the teams successfully the demonstrating are clinical mask Our benefits ResMed of
maintaining grew in During this category year-over-year the highly good players our share in X% in business field accessories and all a the market. with masks market quarter, competitive globally.
physicians, highly our important the CEO, the n therapists patients. just most look mask technology to this for and bringing achieved excited and and approval soon. market that have it test personally this latest customer, mask favored by to our and especially equals new data respiratory from we are forward innovation I our regulatory have worn is We to not and reimbursement show, X greatest
their to of in In better physicians our leads is resupply customer. and and and using resupply and better patient directly maintaining adherence and to providers shows the proving commercial by partner programs to This with patient that clinical to terms Peer-reviewed drive growth with real-world outcomes. programs our mask teams of momentum patients. continue clinical customer published accessory evidence out
AirView and our subscription patients. continue control home We in Brightree of our the their mask, to focused the in U.S., suffocation epidemic help programs, launching We're services respiratory ensure consumers treat the U.S. solutions equipment and years when growth health. in health own and to direct their strong uptick own seen see has Outside and hygiene to refreshing needs for clean programs scaling health and are ecosystem, for business, by their providers their digital COVID-XX customers own they fresh started. since health meet equipment accessories.
The tubing, and and myAir humidifier their medical eyes supporting respiratory developing, X with on of are ago other we sleep engage to permanent care best mask their own where resupply consumers accessories powered directly digital physicians, including for and take the outreach our a improve and to of and and their importance have
mask have we've some success.
Last updates to platform growth steps long-term across We be that power increased out areas discussed health we even drive we will I focused to technology in ensure stopped investments technology quarter, more review that working can to including our and our refocus well strategic and development. projects to investment Before profitable were digital as taken pivotal long-term I success, that device to our not and the like priorities, growth. as discuss key accelerate our recent we ResMed and I'd taken on actions profitable
product-led, enhanced. model even new on making ResMed and more We more more operating even have centered introduced a brand customer-centric even
new operating while in We value the the product will in well measure as an the as accelerating innovation increase success of ResMed of this model velocity XXXX growth. new by enhanced profitable brand
it a of technology great invention and to when not innovation chooses is it. just pay new for adopts As of a is founder the it, loves ResMed states, customer
an have legacy an pipeline to and bring exciting market. product to incredible We
tech grow now business. turn key health design Let's differentiate a is is med market-leading Number worldwide. core X deliver our health can hospital develop the X scaled X preferably the that digital health and to our world's plus priorities.
Number of breathing sleep to is create in solutions and to discussion solutions countries X Number and delivered leverage and strategic and the to care outside and XXX be in software for best and home.
raising strategic priority, patients ramping X, XXXX and up find for In of and to pathways creating specific the world's on in clear laser-focused the suffocation We're to terms generation demand for access sleep markets. apnea as addressing in of health. our We're sleep field leader number care global breathing across awareness initiatives.
demand We screening, and are about pathways. generation investing to who way leveraging diagnostic, in are concerned management social campaigns to cost-effective and traditional own health media-driven help treatment their their sleep into and consumers care channels find breathing
to is on digital concierge provide goal guide help Our a service people to care health that journey.
our and patients more which ecosystem, XX user where their We now new health well care better journey than records sleep app better as in patient a starts in to physician contains and provider-based patient are myAir, million tracking patient in choose as own participate personalized is which starts breathing. the to new
are over X billion on more drive increasing from an of Pharma. Our X worldwide tech help that and patient the flow, who consumer from goal people influence to and have is more Big megatrends X that cost channel. our into need big effectively can There X the
have sleep treatment and sleep issues issues one maintaining for both, taking could big is platform. insomnia, have this a discovering insomnia sleep have they talk tracking that waves or wellness. apnea find enhance into during be goal area sleep help tracking to Watch into Ultimately, if lead chronic a tracking ResMed but of to the as plans of built wellness sleep the its latest not doing a megatrends.
Many of journey. me increasing ] companies We health and have with have is sleep their well, they comorbid condition. for will WHOOP from the own of sleep in consumers only XX% high sleep, of these overall. sleep has for the wellness to they Fitbit sleep screening person entire has focus to wellness built of each [ be pathway of helping the with out Let and people better the move with quality lives for plans spend are will that to Samsung diagnosis, has breathing consumer sleep person sleep. ongoing health issues tracking is they to on same. Apple assessment. sleep educate and about state of briefly define is of called there growth This many field biggest of its care these consumer their And with operating increasing built Apple into COMESA awareness ResMed wellness from its state or love person understand management patient apnea. control pathway each further this our tracking latest-generation architecture, technologies they true platform, quality their sleep. Google's [indiscernible] capability the tech wellness help attention of the best division that into on they and to maybe through their sleep
medications. is squarely the big current megatrends of focus terms of from In impact the GLP-X pharma, on
new you patients and I'll pressure we among anatomy the as briefly on positive address that what as important risk in included X.X stated both for GLP-X remains. Around investor and X latest-generation medications GLP-X thought seeing therapy. ago, at patients be case deck, pressure therapies likely airway months so observed. and remain we likely would website, physics prescriptions them a Let with review start was airway geometry, summarize with option. the Still, me basic medications that and our positive was do, pressure market such factors and theory the These therapy are take million there to in on still in to there data what the age GLP-X of but patients cohort some this unchanged therapy. gender, craniofacial upper time have tracking not less the market despite are airway therapy. airway our this some can We're would the time of over on pharmaceutical a the We positive
at now have real-world data So we real-world evidence and scale.
that opposite. shows reduction patients a analysis not prescriptions the positive airway GLP-X only of is the with XXX,XXX not start therapy, it in over there propensity pressure is to Our exact
of who is XX% an patients been GLP-X, airway positive prescribed pressure of there increase have patients For of the absolute therapy. percentage a commence that
And therapy. you take those same the of a example, patients certain of the prescription airway would their that commence XX% medications. majority So by group, a after in patients latest average these were become baseline of who on an commence GLP-Xs XX% are GLP-X positive therapy a pressure as that PAP vast would way, if vast, of generation the that on
would patients XX population on showed therapy therapy a the about cohort months of Another general over patients increase world an rate therapy opposite. to in X.X therapy, rate on with PAP or was data, hypothesis CPAP million The general ago the plus and GLP-X quit from population shows exact the their months APAP their PAP, time. XXX after resupply prescribed PAP [indiscernible] a again, at basis their a X than commencement over points. that PAP delta of real the population At higher PAP GLP-X
that PAP example, population population both XX%, was it then become rate at an as general over again, prescribed population both PAP resupply XXX So This was, increases delta being say, for XX from at therapy. for points months general further and higher the prescribed to with PAP GLP-X XX% months and actually GLP-Xs. would resupply the going the a the delta XX receiving time population basis if
triumvirate the nutrition, patient in aspects we regular rest at best may triumvirate is outcomes. Here Bilderment, a what two, That peace, diet the and medicine, good We X the whole the believe of of sleep founders in of of results of exercise, and that health. addressing in breathing. all and three, one cardiovascular one, field balance, called believe the including combination ResMed, sleep treating Professor person, he
therapies, not get patients this treatment need by them therapies device good adhere that platforms second-tier help for we technology health peer-reviewed breathing, digital sleep can scaled can't dental to Europe find those global we good more device that just including XD sleep our achieve for as published investing market-leading in positive adherent has we PAP for best-in-class to their to and alternatives. market-leading XX% and in to In XX% of Even are Narval apnea that pressure over airway than with who and solutions, ]. for myAir we XX%. AirView technology, with sleep terms apnea, do of of ResMed best-in-class [ at and adhere goal such achieving invested dental path called still We patients these research We're have our working have physicians patients of patients. [ combining devices ] printed to and where alternative the demonstrating
other sleep need In for in technology [indiscernible] the to company, with alternatives well bottom therapies. for then not addition, We and next we sleep. we agents third-tier start We the stands this, breathing CPAP, respiratory a of investments our care take medicine, treatment path APAP nerve apnemed decades lowest including huge solutions as stimulation decade, pharmaceutical bilevel and cost, efficacy nice good therapies, sleep patient. CPAP of want investment.
ResMed and our decades, hypoglossal and today our as good therapies, X have a the obviously people including every investment highest and better breathe to the beyond. the with and line find we through The want patient is help X And work to to apnea person number with
XX talk moment connectable leveraging to our ecosystem. health investments, and data the of the deidentified pivot XX.X million medical digital nights about cloud our billion for Let's XXX% a in devices technology
equipment better investing we that actions continuing prioritize products Compliance coach ecosystem data call talking to the AI digital and that navigate consumers, a helps struggle will data engage identify, potential will questions they to publicly compliance best who providers drive both particular better home requirements are and options.
This controlled and their their that to patient of over out, serves about algorithms will patients. marking The of improve customers not on generative drive launch. journey personal in sleep-concerned the adhere beta for in launched as intelligence-driven and/or models HME artificial group. may on We capabilities are the sleep-related patients and digital our that business solution wellness and breathing. ask of to for information We provider, predict a coach is We're test across billions final a U.S. personal results and AI therapy to a probability for which generative globally AI enroll the recently a help patient outcomes using and Asia product called update then technology to launch one their and adherence about, they at a to AI and a time. its of better meet tool solutions. Customers outreach for their to to the see to on starting we a identifies this person quarter. as the and takes and in We're product Pacific, their human an several built based we're ResMed treatment concierge excited is medical market are the initial sleep roll lower patient compliance to helps this scale sleep on currently in digital product in market very One people coach cost.
Compliance look to compliance the positive developed to in-market that likelihood and product maximize points. or trial group key that call search across further we in step
and digital those best Our seeking sleep goal sleep their the for and care. better scale breathing can best all outcome, long-term concierge develop and better the pathway is personal this the to so best find treatment that
ventilator our support as ventilator platforms be supported Our sustained our well as to activity Health Respiratory platforms. across noninvasive life by business continues
economic call that in flow invest the we to clinical treat HFT therapy cost even high and to We trials more COPD for in effectively continue home.
well will develop we we continues COPD we prevalence generate these disease care as offer high-quality to evidence and as conditions epidemic. this to that home. As support will innovations these and clinical of treating low-cost, due for broader next-generation respiratory neuromuscular of strong therapies, respiratory treatments insufficiency economic to adoption address health outcomes increase. help at The
Ongoing Brightree a brand Residential DAN of our Germany. both between driving in solid our our brands. MEDIFOX offering business medical had and health the from with synergies home in our equipment remains great business customer-facing Service to Care across resupply our very contribution MatrixCare of Organic full another quarter business. sleep SaaS with business, strong, quarter our year-over-year across we was growth another and growth U.S. growth our SaaS revenue core good our our as and XX%. Software Turning Brightree
health, the expect beyond organic as double-digit growth achieve home SaaS We stable and in continue of year have fiscal XXXX nursing organic portfolio home sustainable we year single beyond. solutions to and equipment, home in and fiscal across digits this our through medical to growth high through to be
to entire for operating interoperability capabilities management operating we and our SaaS of growth capabilities ResMed to portfolio business. continue the across We technology through expense across drive net and leverage our cloud plan compute, our development accelerate profit for and cybersecurity,
integral of SaaS business and care and remains residential care. residential solutions health the breathing of and our software device solutions sleep provider complements Our leading global well SaaS for part market-leading growth strategy. market-leading strategic are that positioned we business health as an have we This the the ResMed's business, in
medicine We and scale. respiratory residential at are transforming care
and We adopting are digital leading the markets. in industry across health our applying developing, technology
on in accelerate to efficiencies efficiencies continue operations. growth, driving We're line We top increased cost and drive focused to focused revenue our scale and discipline profitability.
we and market-leading million long-term the clear smallest, improve shareholders. mission intelligent industry comfortable, for health lives the and revenues most most in mission patient-centric This of digital lead stop products health day. residential created most soon. motivates and research plan connected care anytime our ResMedians remains to We through X% sustainable to have development. around straight driving every technology and don't and XXX our in solutions, We quietest with customers worldwide, better solutions We differentiated ResMed's value into invest me back innovating XXXX. crystal for
Thank provides last delivered we to software to have to very sleep higher-quality the directly each a or of We've have the live breathe I'm opportunities I pipeline XX,XXX gratitude to want than live. health sincere dedication over front complete you.
With to that, XX for or hand we'll months, to device Brett we a better the Over then helped digital ahead.
In best-in-class and and patient. their express Q&A remarks, they Sydney every us over better, for care mask patient the work you, in his system that in open delivering their and about my lives XXX to to a medical personal by a During improved solution ResMedians closing, lives and I'll Brett a person and today right health the up and Brett. excited a the million where day. with to call more or team. to hard for for perseverance, care me patient
